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test in SVS Version 7.5 software (Golden Helix, Inc.) . 155
For replication analysis, we selected 68 and 98 SNPs assigned to WWC1 (5q34: 167651670 -167829334 156 bp) and TLN2 (15q22.2: 60726802 -60920733 bp), respectively, according to NCBI B36 genome 157 assembly (SNP list is provided in Table S2 ). We did not consider SNPs from any regulatory regions 158 outside WWC1 and TLN2 genes. Thus, all the SNPs falling into the boundaries of WWC1 and TLN2 genes 159 and typed in all the study cohorts (discovery EADI1 and the 3 replication cohorts: GERAD1, RS, and 160 ADGC) were exhaustively tested for two-way intergenic interactive association with AD, in males and 161 females separately. We used logistic regression adjusted for age and genetic population stratification as 162 before. The number of independent tests (Nyholt, 2004) 
was 1564 (of 6664 total). All obtained p-values 163
(not corrected for multiple testing p nominal ) for EADI1, GERAD1, RS, and ADGC were meta-analyzed 164 using Fisher's combined p-value (Fisher, 1948 ) and Stouffer's Z score (Stouffer et al., 1949) 
methods, 165
giving rise to meta-analysis p-values (p meta ). Details on the applied significance criteria are described in 166 the Note 4. 167 168
Functional analysis and biological validation 169
We used transcriptome analysis to assess co-expression of WWC1 and TLN2 in temporal cortex and 170 cerebellum human brain regions with data from the brain expression GWA study (eGWAS) (Allen et al., 171 2012; Zou et al., 2012 ) (Note 5). The laboratory fruit fly Drosophila melanogaster was used to further 172 explore the role of WWC1 and TLN2 in model organisms (Note S6). In addition, formalin-fixed temporal 173 cortexes of male AD patients were used to perform brain immunohistochemistry (Note S7). The latter was 174 performed in 2 independent labs to robustly establish reproducibility. To assess sub-cellular localization of 175 WWC1 and TLN2, we performed immunofluorescence and confocal microscopy analyses (Note S8). We 176 also investigated the presence of WWC1 and TLN2 in the same complex via immunoprecipitationM A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT 9 analysis (Note S9). Molecular mechanisms of interaction between WWC1 and TLN2 were modeled via 178 protein docking (Note S10) and molecular dynamics in silico experiments (Note S11). 179
The entire analysis protocol is described in Fig. 1.  180   181 
Results 182

Synergy between variants of WWC1 and TLN2 in association to AD 183
Both parametric (BOOST) and non-parametric (MB-MDR) analyses highlighted epistasis between the 184 SNPs rs3733980 and rs7175766 (MAFs=0.365, 0.307 in EADI1, respectively) as genome-wide significant 185 in males (BOOST: p Bonferroni-corrected =0.018, MB-MDR: p permutation-based =0.005). Case/control distributions 186 within the 9 multi-locus genotype combinations and MB-MDR "high risk"/"low risk" labelling are in the 187 Table S3 . Only rs3733980 also showed a main effect (p nominal =0.015, trend test), which would not 188 withstand stringent multiple testing correction. The identified epistasis signal remained statistically 189 significant in a logistic regression model accounting for age and the first 4 PCs (p Bonferroni-corrected =0.0165). 190
The APOE gene did not confound the identified interaction, since we found no dependence between the 191 APOE ε4 AD-risk allele and the 9-level categorical SNP pair for these SNPs, ߯ ଼ ଶ ). No female-specific 192 epistasis was identified (BOOST, 
Statistical replication of epistasis between WWC1 and TLN2 195
We considered all pairwise intergenic interactions between the directly-genotyped 68 SNPs of WWC1 and 196 98 SNPS of TLN2 (Table S2) for follow-up replication analysis in both sexes with the GERAD1, RS and 197 ADGC datasets. In males, the SNP-pair rs3733980 and rs7175766 was significant in a single study 198 and TLN2 gens were observed (Table S6 ). 214
We also tested whether WWC1 and TLN2 could modulate AD physiopathology in human Tau (2N4R)-215 expressing Drosophila, an in vivo model of AD (review (Gistelinck et al., 2012) ). Kibra, ortholog of 216 WWC1 ( Fig. 2A , 2B and 2C), and rhea, ortholog of TLN2 ( Fig. 2A, 2D and 2E), were tested as modifiers 217
of Tau toxicity in Drosophila eye. In Drosophila, kibra belongs to the growth controlling Hippo pathway. 218
Gain (loss) of kibra results in smaller (bigger) eyes (Baumgartner et al., 2010) , which we also observed 219 ( Fig. 2A and B) . Expression of human Tau (2N4R) in the eye with the GMR driver resulted in smaller 220 rough eyes. The eye size was partially restored in kibra 2/+ haploinsufficient background, upon RNAi-221 mediated knockdown of kibra ( Fig. 2B and 2C ) and in rhea 1/+ haploinsufficient background ( Fig. 2D and 222 2E). Coexpression of kibra with Tau resulted in lethality and the only escapers that we obtained had 223 smaller eyes. For kibra knockdown and kibra overexpression, the effect may be additive as in both 224
conditions without Tau expression, fly eyes are respectively bigger and smaller ( Fig. 2A and B ). For kibra 225 haploinsufficiencies, only 1 out of 4 independent null mutations restored the eye size precluding us to 226 firmly conclude that kibra interacts with Tau in Drosophila eye. The result in the rhea 1/+ haploinsufficient 227 background ( Fig. 2D and 2E ) suggested that rhea interacted functionally with human Tau in Drosophila 228
eye. 229
Immunohistochemistry of the brain of a male autopsied AD patient indicated strong expression of WWC1 230 in the soma of neuronal cells throughout the temporal lobe of the cerebral cortex (Fig. 3) . In these neurons, 231 WWC1 presented in the cytoplasm with presumed membrane and/or cytoskeleton associations and strong 232 neuritic accumulations in some cells. TLN2 also presented in the cytoplasm of neuronal cells, although 233 immunoreactivity was low. In addition to the weak neuronal signal, a strong TLN2 signal was detected in 234 the endothelial cells of blood vessels. 235
We also performed co-immunofluorescent staining analyses of human Braak I and Braak VI brains (Braak 236 and Braak, 1991) (Fig. 4) . After performing quantitative pixel intensity spatial correlation analysis 237 (extracting Pearson's, Manders', and Costes' parameters (autothreshold and randomization) (Bolte and 238 Cordelieres, 2006)), we determined that TLN2 (Talin2) and WWC1 (aka KIBRA) co-localized in all 239 cases. Interestingly, WWC1 staining appeared to be more cellular in Braak I compared to Braak VI tissue, 240 where the staining appeared stronger and more widely distributed. 241
In complement, we confirmed co-localization of WWC1 and TLN2 in HeLa cell lines and in mouse N2a 242 neuroblastoma cells. When overexpressed in HeLa cells, WWC1 displayed diffuse cytoplasm localization 243 and small perinuclear rings (Fig. 5, Flag-WWC1 ), and TLN2-GFP displayed cytoplasmic focal adhesion 244 localization with elongated fibrillar adhesions through the cell body (Fig. 5, TLN2 -GFP), consistent with 245 previous studies (Kremerskothen et al., 2003; Praekelt et al., 2012) . Co-expression of both WWC1 and 246 TLN2 dramatically changed TLN2 localization. In the presence of WWC1, TLN2-GFP appeared 247 concentrated in cytoplasmic foci (Fig. 5 , compare GFP staining for TLN2 and WWC1+TLN2) surrounded 248 by Flag-WWC1 rings (Fig. 5, WWC1+TLN2 -GFP, merge image). In N2a cells, WWC1 and TLN2 wereM A N U S C R I P T
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found to co-localize in cytoplasm and in filopodia-like protrusions (Fig. S1 ). However, different co-250 localization patterns observed in N2a cells may be due to different levels of the proteins expressions. 251
Furthermore, immunoprecipitation analysis (IP) both in human brain samples and in HEK293 cells 252 indicated the presence of WWC1 and TLN2 in the same protein complex. The levels of the two proteins 253
were variable in all conditions and brain regions queried (Braak I and Braak VI brains (Braak and Braak, 254 1991) , Fig. 6A (upper panel) ). WWC1 co-immunoprecipitated with the anti-TLN2 antibody (Fig. 6A  255 (lower panel)); as expected, TLN2 bands were evident in the western blot. Interestingly, when the WWC1 256 antibody was used, TLN22 bands were absent (Fig. 6A (lower panel) . These data suggest that the anti-257 WWC1 antibody could competitively disrupt the TLN2 and WWC1 interaction. In HEK293 cells, TLN2-258 GFP specifically co-purified with Flag-WWC1 when both proteins were overexpressed together (Fig. 6B) . 259
To model molecular mechanisms of interaction between WWC1 and TLN2 we performed protein docking 260 and molecular dynamics (MD) in silico experiments. We determined the top 10 ranked WWC1/TLN2 261 poses (Fig. S2) via ClusPro 2.0 docking server (Comeau et al., 2004a, b; Kozakov et al., 2006) . Poses 2 262 and 7 showed the most favorable conditions for complex formation as their average MM/PBSA protein-263 ligand binding free energies (dG bind ) were amongst the most negative showing the lowest dispersion over 264 the course of the 50 ns aqueous simulations. In all 50 ns MD simulations, WWC1 and TLN2 remained 265 physically associated in a complex throughout the entire course of simulation. The average dG bind 266 remained negative for all 10 poses (dG bind ranged from -16 to -227 kJ/mol indicating the size of the 267 binding affinity between the two proteins; Table S7 and Fig. S3) . Interestingly, recent studies identified several other components of the cell adhesion pathway as modifiers 282 of Tau toxicity in Drosophila (Dourlen et al., 2016; Shulman et al., 2014) . Studying the mechanisms of 283 the identified epistatic interaction, we performed comprehensive functional biological experiments. 284 WWC1 and TLN2 were co-expressed in the temporal cortex brain tissue (responsible for learning and 285 memory) of AD subjects, co-localized in both brain tissue cells, in neuroblastoma N2a and HeLa cell 286 lines, and co-immunoprecipitated both in brain tissue and HEK293 cells. The physical interaction between 287 WWC1 and TLN2 was also supported by in silico experiments where the binding affinity between the two 288 proteins was pretty strong with favorable conditions for forming a stable protein complex. 289
We may speculate on the involvement of WWC1 and TLN2 in common signaling pathways connected to 290 signal transduction via synapses that are impaired when dementia symptoms and AD progress. Since 291 overexpression of WWC1 was previously associated with AD (Burgess et al., 2011) , we speculate that 292 impairment expression of WWC1 and/or TLN2 proteins may destabilize actin filaments. Additional work 293 is required to further describe a functional interplay between WWC1 and TLN2 and to explain why we 294 observed the interaction at an individual level for both sexes, whereas we could detect association with 295 AD only in males at a population level (despite of the theoretical power loss for epistasis detection in a 296 sample stratum of males). A few explanations are possible and should be investigated in detail: the 297 influence of sex hormones on the epistasis manifestation, the involvement of a third interacting component 298
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(i.e., an interacting gene) linked to the sex chromosomes, other types of sex-specific variant(s) in WWC1 299 and TLN2, among others. Regardless, our findings provide impetus for an in-depth search of AD-related 300 mutation(s) in WWC1 and TLN2 genes to better explore and grasp biological mechanisms underlying the 301 identified sex-specific epistasis signals. Targeted next-generation sequencing of the interacting genes may 302 facilitate the identification of new functional mutations (either common or rare) that play a role in protein 303 structure, stability, solubility, folding, and affinity of interaction with ligand(s), to name a few. 304
There is still a big divide between statistical epistasis and biological epistasis. The ambition in 305 detecting statistical epistasis is to close this gap by improved analysis protocols and to formulate 306 guidelines towards the interpretation of statistical findings in the context of epistasis. The field 307 has evolved a lot over the last decade, in this sense. This does not change the fact that indeed, 308 the power of a genome-wide epistasis screening (GWAI analysis) using a single study is much 309 smaller than the power of a corresponding main effects GWA analysis using the same data 310 (Gauderman, 2002). Our experience with large-scale epistasis studies is consistent with this, 311 usually only giving rise to 1 or 2 reliable statistical findings (that is, findings for which we can 312 rule out numerical instability issues or strong main effects overtaking the joint effects of the loci 313 involved). Regardless, results dating back from already suggested that biological inference from 314 statistical models is not an utopia (Moore, 2005) . 315
Conclusion 316
In this research we aimed to identify novel gene/protein targets to pave the way towards novel 317 biochemical pathways related to AD via SNP panels as a starting point. By following a rigorous analytic 318 genome-wide epistasis detection protocol (Gusareva and Van Steen, 2014) , which minimizes false 319 positive findings and enhances functional relevance, the statistically replicable epistasis was identified. A 320 series of biological experiments indicated novel protein-protein interaction between WWC1 and TLN2 321 that can potentially be a medical target for the cure of AD. To our knowledge, this is the first report in AD 322 M A N U S C R I P T
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